Logo image
Intravenous and intra-arterial administration of bone marrow mononuclear cells after focal cerebral ischemia: Is there a difference in biodistribution and efficacy?
Journal article   Peer reviewed

Intravenous and intra-arterial administration of bone marrow mononuclear cells after focal cerebral ischemia: Is there a difference in biodistribution and efficacy?

Andreia Vasconcelos-dos-Santos, Paulo Henrique Rosado-de-Castro, Sergio Augusto Lopes de Souza, Juliana da Costa Silva, Alane Bernardo Ramos, Gabriel Rodriguez de Freitas, Lea Mirian Barbosa da Fonseca, Bianca Gutfilen and Rosalia Mendez-Otero
Stem cell research, Vol.9(1), pp.1-8
07/01/2012
DOI: 10.1016/j.scr.2012.02.002
PMID: 22445868

View Online

Abstract

Intravascular delivery of cells has been increasingly used in stroke models and clinical trials. We compared the biodistribution and therapeutic effects of bone marrow mononuclear cells (BMMCs) delivered by intra-arterial (IA) or intravenous (IV) injection after cortical ischemia. For the biodistribution analyses, BMMCs were labeled with (99m)Technetium (Tc-99m). At 2 h, gamma-well counting of the brain and of the other organs evaluated did not show differences between the non-ischemic and ischemic groups or between injection routes, and the organs with the highest uptake were the liver and lungs, with low uptake in the brain. At 24 h, the liver maintained the highest activity, and a marked decrease was seen in pulmonary uptake in all groups. At this time point, although the activity in the brain remained low, the lesioned hemisphere showed greater homing than the contralateral hemisphere, for both the IV and IA ischemic groups. Histological analysis by CellTrace labeling indicated similar homing between both routes in the pen-infarct region 24 h after transplantation and functional recovery was observed in both groups up to 11 weeks after the lesion. In conclusion, transplantation of BMMCs by IA or IV routes may lead to similar brain homing and therapeutic efficacy after experimental stroke. (C) 2012 Elsevier B.V. All rights reserved.
Biotechnology & Applied Microbiology Cell & Tissue Engineering Cell Biology Life Sciences & Biomedicine Science & Technology

Details

Metrics

1 Record Views
Logo image